Xcout IntelDynavax competitors & alternatives
The 12 closest competitors and alternatives to Dynavax among biopharmaceuticals companies — ranked by similarity to what Dynavax actually does, not by market-cap band.
Subscribe to see Dynavax’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Dynavax
Dynavax Technologies Corporation is a biopharmaceutical company developing and commercializing vaccines, including HEPLISAV-B, a hepatitis B vaccine for adults. It also develops CpG 1018, an immune-stimulatory adjuvant used in vaccine development and partnered programs.
Dynavax at a glance
Dynavax is a biopharmaceuticals company. Xcout tracks 13 named people at Dynavax, including Ryan Spencer (Chief Executive Officer).
Dynavax leadership
- Ryan SpencerChief Executive Officer
- David NovackPresident and Chief Operating Officer
- Kelly MacDonaldChief Financial Officer
- Andrew DavisChief Business Officer
- Donn CasaleChief Commercial Officer
- Jeff CoonChief Human Resources Officer
7 more named people on record for Dynavax, with roles, board committees and tenure — see the full roster →
Recent Dynavax news
Top 12 Dynavax competitors
Ranked by semantic similarity — how close each company is to Dynavax by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biopharmaceuticals company
HilleVax, Inc. is a biopharmaceutical company headquartered in Boston, Massachusetts, established through a collaboration with Takeda and Frazier Healthcare Partners. The company focuses on developing and commercializing Takeda's norovirus vaccine candidate.
Similar biopharmaceuticals company
Acelyrin, Inc. is a clinical-stage biopharmaceutical company developing medicines for immune-mediated diseases. Its lead program, izokibep, is an interleukin-17A inhibitor intended to treat inflammatory conditions such as hidradenitis suppurativa and psoriatic arthritis.
Similar biopharmaceuticals company
Chimerix, Inc. is a biopharmaceutical company that develops medicines for oncology and other critical illnesses, serving US-based healthcare audiences and patients.
Drug Discovery
MinervaX is a privately held biotechnology company headquartered in Copenhagen, Denmark, pursuing the development of a novel maternal prophylactic vaccine for the prevention of Group B Streptococcus disease.
Similar biopharmaceuticals company
Cidara Therapeutics, Inc. is a biotechnology company focused on developing late-phase antiviral and immunotherapy agents, with operations based in San Diego, California and Rahway, New Jersey.
Similar biopharmaceuticals company
Achaogen Inc was a biopharmaceutical company headquartered in South San Francisco, California. The company focused on discovering, developing, and commercializing novel antibacterial treatments.
Similar biopharmaceuticals company
Dermira, Inc. is a biotechnology company focused on medical dermatology, with its main headquarters located in Menlo Park, California, United States.
Similar biopharmaceuticals company
ChemoCentryx, Inc. is a biopharmaceutical company with its corporate headquarters and principal place of business located in California.
Similar biopharmaceuticals company
Emergent BioSolutions Inc. is a life sciences enterprise dedicated to developing and delivering solutions for preparing for and responding to diverse public health threats (PHTs) in the United States. Its mission involves countering unforeseen, intentional, and naturally arising health crises affecting populations. The company's product portfolio addresses a wide spectrum of PHTs, encompassing chemical, biological, radiological, nuclear, and explosive agents (CBRNE), emergent infectious diseases, travel-related health concerns, and immediate emergency medical needs. Among its key commercialized offerings are: Vaccines: BioThrax (for anthrax), ACAM2000 (for smallpox), Vivotif (an oral immunization against typhoid fever), and Vaxchora (a single-dose oral vaccine for cholera). Treatments & Antidotes: Botulism Antitoxin Heptavalent (combats botulism), vaccinia immune globulin intravenous (manages adverse reactions to smallpox vaccination), raxibacumab and Anthrasil (both for treating and preventing inhalational anthrax), and NARCAN (a nasal spray for immediate intervention in known or suspected opioid overdoses). Other Emergency Preparedness: Reactive skin decontamination lotion kits, and Trobigard, an investigational auto-injector product combining both drug and device components. Furthermore, Emergent BioSolutions boasts an active development pipeline, featuring candidates such as AP003 (a multidose Naloxone nasal spray), AP007 (a sustained-release Nalmefene injection for opioid use disorder), AV7909 (an anthrax vaccine), CGRD-001 (a pralidoxime chloride/atropine auto-injector), CHIKV VLP (a chikungunya virus-like particle vaccine), COVID-HIG (a treatment for SARS-CoV2), EGRD-001 (a diazepam auto-injector), SIAN (an antidote for acute cyanide poisoning), and UniFlu (a universal influenza vaccine). Beyond its proprietary products, the company also provides comprehensive contract development and manufacturing (CDMO) services. These services include drug substance and product manufacturing, packaging solutions, alongside specialized expertise in technology transfer, process optimization, and analytical development. Established in 1998, Emergent BioSolutions maintains its corporate headquarters in Gaithersburg, Maryland.
Similar biopharmaceuticals company
CSL Behring is a global biotechnology company that develops and provides plasma-derived and recombinant therapies. Through its divisions, the company delivers treatments for rare and serious diseases, influenza vaccines, iron deficiency, and nephrology conditions to patients worldwide.
Similar biopharmaceuticals company
Arpida AG was a Swiss biopharmaceutical company focused on developing novel anti-infective drugs, notably the antibiotic iclaprim for serious bacterial infections including those caused by resistant Gram-positive pathogens such as MRSA. Its intended customers and beneficiaries were hospitals, healthcare providers, and patients requiring treatment for serious bacterial infections.
Similar biopharmaceuticals company
CAGE Bio is a clinical-stage biotechnology company that develops localized therapies for dermatology, inflammation, and immunology. The company utilizes a proprietary deep eutectic ionic liquid platform to enable the skin penetration of small and large molecules, providing topical treatments designed to avoid the side effects of systemic drug exposure.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Dynavax and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Dynavaxand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →